ConductScience.org, home

Paper37726886

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.

Panneerselvam S and 6 others. Cell Adh Migr, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Papers, record 37726886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37726886

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.
PubMed
Journal
Cell Adh Migr
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2023-10-04
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Panneerselvam SSuganhttps://orcid.org/0000-0002-9698-3843
2Wilson CCornelia
3Kumar PPrem
4Abirami DDinu
5Pamarthi JJayakrishna
6Reddy MSMettu Srinivas
7Varghese JJoy

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Humans
Molecular Targeted Therapy
Mutation

References162

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121135505Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.J Clin Invest2011https://conductscience.org/library/papers/21135505PubMed
220196837Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.J Exp Clin Cancer Res2010https://conductscience.org/library/papers/20196837PubMed
332730345Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.PLoS One2020https://conductscience.org/library/papers/32730345PubMed
433808740A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?Cancers (Basel)2021https://conductscience.org/library/papers/33808740PubMed
533748726NAFLD and MAFLD as emerging causes of HCC: A populational study.JHEP Rep2021https://conductscience.org/library/papers/33748726PubMed
634629183Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.Mol Aspects Med2021https://conductscience.org/library/papers/34629183PubMed
728137313The evolving concept of liver cancer stem cells.Mol Cancer2017https://conductscience.org/library/papers/28137313PubMed
836293184Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.Int J Mol Sci2022https://conductscience.org/library/papers/36293184PubMed
934440803NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.Cells2021https://conductscience.org/library/papers/34440803PubMed
1034329775Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34329775PubMed
1134506016CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.J Gastrointest Surg2022https://conductscience.org/library/papers/34506016PubMed
1223712051Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.J Hepatol2013https://conductscience.org/library/papers/23712051PubMed
1331728429Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?Transl Gastroenterol Hepatol2019https://conductscience.org/library/papers/31728429PubMed
1435938354Blockade of T-cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV-related HCC in mice.Hepatology2023https://conductscience.org/library/papers/35938354PubMed
1525421688Detection of epigenetic aberrations in the development of hepatocellular carcinoma.Methods Mol Biol2015https://conductscience.org/library/papers/25421688PubMed
1622655206Hepatocellular carcinoma: focus on different aspects of management.ISRN Oncol2012https://conductscience.org/library/papers/22655206PubMed
1727006468C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.Oncotarget2016https://conductscience.org/library/papers/27006468PubMed
1828595519T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.Immunotherapy2017https://conductscience.org/library/papers/28595519PubMed
1924457013Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Semin Cancer Biol2014https://conductscience.org/library/papers/24457013PubMed
2028626852Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).J Gastrointest Cancer2017https://conductscience.org/library/papers/28626852PubMed

See all 162 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42934724The evolving role of TP53 mutation in hepatocellular carcinoma (HCC).Cancer Cell Int2026https://conductscience.org/library/papers/42934724PubMed
42883895Unveiling Novel Molecular Candidate Targets of Loratadine, Raloxifene, and Sorafenib in Hepatocellular Carcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/42883895PubMed
41589205Role of insulin-like growth factor/receptor signaling in hepatocellular carcinoma.Hepatol Forum2026https://conductscience.org/library/papers/41589205PubMed
40702000RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.Cell Death Discov2025https://conductscience.org/library/papers/40702000PubMed
40584445Effect of Crocus sativus L. (saffron) and Rosmarinus officinalis L. (rosemary) in hepatocellular carcinoma: A narrative review of current evidence and prospects.Iran J Basic Med Sci2025https://conductscience.org/library/papers/40584445PubMed
39598228The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges.Life (Basel)2024https://conductscience.org/library/papers/39598228PubMed
38634139The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.Technol Cancer Res Treat2024https://conductscience.org/library/papers/38634139PubMed
38612504Underlying Mechanisms behind the Brain-Gut-Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.Int J Mol Sci2024https://conductscience.org/library/papers/38612504PubMed
38148326Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.Cancer Biol Med2023https://conductscience.org/library/papers/38148326PubMed

Download CSV of cited by

Genes146

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
ADH1C126PubTator's text mininghttps://conductscience.org/library/genes/126NCBI Gene
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
AIRE326PubTator's text mininghttps://conductscience.org/library/genes/326NCBI Gene
AKR1A110327PubTator's text mininghttps://conductscience.org/library/genes/10327NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ANGPT1284PubTator's text mininghttps://conductscience.org/library/genes/284NCBI Gene
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
ARID1B57492PubTator's text mininghttps://conductscience.org/library/genes/57492NCBI Gene
ARID2196528PubTator's text mininghttps://conductscience.org/library/genes/196528NCBI Gene
ASGR1432PubTator's text mininghttps://conductscience.org/library/genes/432NCBI Gene
ASS1P1442167PubTator's text mininghttps://conductscience.org/library/genes/442167NCBI Gene
AXIN18312PubTator's text mininghttps://conductscience.org/library/genes/8312NCBI Gene
BCORL163035PubTator's text mininghttps://conductscience.org/library/genes/63035NCBI Gene

See all 146 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37726886

GET https://conductscience.org/api/papers/v1/37726886/references?page=2